Researchers Find 15% of Trials Could be Replicated Using Real World Data

A study published this week in JAMA Network Open finds that currently available real-world data (RWD) sources can only be used to feasibly replicate 15% of clinical trials.

The aim of the study was to determine whether RWD could be used to power observational studies that answer the same clinical questions as traditional clinical trials.